Merlin, Inc. (MRLN) draws limited coverage from Wall Street, yet six current price targets stand out as verifiable. They range from $4.00 to $10.00, averaging $7.92 before rounding to the $8 central figure. Recent updates include TD Cowen (Gautam Khanna) lowering its target to $4.00 from $8.00 while retaining a Buy rating on October 9, 2026; Canaccord Genuity initiating at $7.50 on September 25; Maxim Group at $7.00; and Northland Securities along with Roth MKM each at $10.00. Cantor Fitzgerald had previously trimmed its target to $9.00 from $11.00 in August.
Every firm in this group maintains a positive rating, with no Holds or Sells present. The optimism centers on the company's AI "pilot" technology for reducing crew needs on aircraft like the C-130J cargo plane. Still, the spread from $4.00 to $10.00 and the downward drift in targets highlight real differences of opinion on commercialization speed and balance-sheet strength. Several targets originated when shares traded well above $1, so the recent drop means some may not fully capture today's conditions. I also checked this using Tickeron’s AI Screener to compare the stock against industry peers.
The stock closed near $0.99 on November 9, 2026, giving MRLN a market capitalization of roughly $100 million. Its 52-week range spans $0.74 to $17.00. Reaching the $8.00 target would require an approximate 700% rise from current levels, a substantial move that would still leave the shares well below earlier highs.
Even the lowest target of $4.00 implies a quadrupling from here, showing how much sentiment has shifted. Any recovery path would likely depend on clear milestones such as stabilized quarterly cash burn, proof that the C-130J program and other opportunities are turning into revenue, and a balance-sheet step that eases dilution and delisting pressures.
The company's technology and liquidity stand as primary supports. Merlin is advancing autonomous flight systems for traditionally piloted aircraft, an area with real defense and cargo demand. It holds a cash position of roughly $183.9 million, which analysts view as offering a multi-year runway for programs like the C-130J. Revenue remains modest yet expanding, at about $6.8 million over the trailing twelve months, with consensus estimates pointing to stronger growth ahead. Confirmed milestones or contract wins could help rebuild confidence.
Significant hurdles remain. The company reports a trailing twelve-month net loss near $610.8 million and negative EPS. A share price below $1.00 raises Nasdaq delisting risks, which can lead to reverse splits that hurt sentiment further. Ongoing losses and possible capital raises create dilution concerns for existing shareholders. Broader market conditions, such as interest rates and appetite for pre-revenue aerospace names, add pressure on this distressed micro-cap. The 92% drop over the past year also suggests some targets may be outdated, as the recent TD Cowen cut already shows.
The technical setup looks weak. The 52-week low of $0.74 from early November 2026 serves as clear support, while the $1.00 level acts as both a psychological barrier and near-term battleground. Recent highs near $1.05 and consolidation around $1.07 to $1.14 mark resistance. Longer-term averages sit much higher, with the 50-day near $1.78 and the 200-day near $6.25, underscoring a broken trend that would need repair before any sustained move toward $8.00.
Analyst targets typically cover a roughly 12-month horizon. Investors should monitor the upcoming earnings report around November 12, 2026, for updates on cash burn, revenue, and guidance; any resulting analyst changes; contract announcements especially tied to the C-130J; financing moves; and regulatory or exchange actions related to the sub-$1 price.
The $8.00 target represents the rounded mean of six analyst estimates from $4.00 to $10.00 and sits about 700% above the latest price near $0.99. While uniform Buy ratings reflect enthusiasm for the AI-pilot technology and cash position, the wide range, recent downward revisions, and 92% annual decline warrant caution. Reaching that level would require not only technical progress but also a reversal of balance-sheet and delisting issues. The supports are tangible, yet the obstacles carry equal weight, and upcoming earnings along with any funding updates will serve as important markers.
In my own process for tracking fast-moving names like this, I turn to Tickeron's AI Daily Buy/Sell Signals for an additional data-driven perspective. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market conditions and technical patterns. It helps surface opportunities and monitor shifts more efficiently, and I find it useful as a complement when following developments in MRLN.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
MRLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 8 of 8 cases where MRLN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MRLN's RSI Oscillator exited the oversold zone, 8 of 12 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 7 of 19 cases where MRLN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 37%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on MRLN as a result. In 10 of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 29%.
The Moving Average Convergence Divergence (MACD) for MRLN just turned positive on October 13, 2026. Looking at past instances where MRLN's MACD turned positive, the stock continued to rise in 7 of 14 cases over the following month. The odds of a continued upward trend are 50%.
Following a +28.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRLN advanced for three days, in 29 of 74 cases, the price rose further within the following month. The odds of a continued upward trend are 39%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for MRLN entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.880) is normal, around the industry mean (5.050). P/E Ratio (0.274) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.090) is also within normal values, averaging (3.110). Dividend Yield (0.024) settles around the average of (0.055) among similar stocks. P/S Ratio (23.148) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. MRLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of equipment leasing solutions to small businesses
Industry AerospaceDefense